Here's how to relieve the itching and get steps on preventing hives and avoiding your triggers. The post Make Hives Disappear ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with ...

Who Is This Treatment For? Chronic spontaneous urticaria, aka CSU, happens when a person develops itchy hives that persist for over six weeks. Their condition may not consistently be controlled by ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

Discover a recent study that investigated the effects of acupuncture and herbal remedies on urticaria. Learn more.

Rilzabrutinib significantly reduces itch and hives in patients with chronic spontaneous urticaria unresponsive to ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for chronic spontaneous urticaria (CSU) ...

This article looks at contact urticaria in more detail, including its causes, risk factors, symptoms, and treatment. Contact urticaria is an immediate and short lived reaction to a certain ...

Understanding the causes, symptoms, treatment options, and why urticaria may worsen at night is essential for effective management. Urticaria is an inflammatory skin disorder. According to the ...

CHRONIC spontaneous urticaria (CSU) is a distressing inflammatory skin condition characterised by the recurrent appearance of ...